House mark used for drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma and diseases and conditions in joints, namely, osteoarthritis, bursitis, fibrotic diseases, and infections

'agent':7 'bursiti':49 'compound':11 'condit':24,44 'consist':8 'deliveri':6,15 'diseas':22,27,36,38,42,51 'drug':5 'edema':34 'facilit':13 'fibrot':50 'glaucoma':40 'hous':1 'includ':25 'infect':53 'joint':46 'macular':33,35 'mark':2 'name':28,47 'occlus':32 'ocular':26 'osteoarthr':48 'pharmaceut':17 'polym':10 'retin':30,37 'treatment':20 'use':3 'uveiti':29 'vein':31

House mark for sustained drug delivery systems for pharmaceuticals

'deliveri':6 'drug':5 'hous':1 'mark':2 'pharmaceut':9 'sustain':4 'system':7

ACUITY PHARMACEUTICALS

Owners

Goods & Services